Batroxobin
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
B02BX03
CAS registry number (Chemical Abstracts Service)
0009039-61-6
Therapeutic Category
Hemostatic agent
Chemical Name
A thrombinlike enzyme obtained from the venom of the serpent Bothrops atrox[WHO ]
Foreign Names
- Batroxobinum (Latin)
- Batroxobin (German)
- Batroxobine (French)
- Batroxobina (Spanish)
Generic Names
- Batroxobin (OS: JAN)
- Batroxobina (OS: DCIT)
- Batroxobine (OS: DCF)
- Reptilase (IS)
- Hemocoagulase (IS)
Brand Names
- Batroxobin - Tobishi
Tobishi Pharmaceutical, China - Botropase
Han Lim, South Korea - Defibrase
Tobishi Pharmaceutical, Japan - Reptilase
Tobishi Pharmaceutical, Japan - Ba Qu Ting
Beida Gaoke Huatai Pharmaceutical, China - Bang Ting
Aohong Pharmaceutical, China - Botroclot
Juggat, India - Botroclot Forte
Juggat, India - Botropase
Juggat, India - Reptilase
Solco Basle, China - Su Le Juan
Zhaoke Pharmaceutical, China - Su Ling
Kangchen Pharmaceutical, China
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
